Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis.
Saved in:
| Title: | Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis. |
|---|---|
| Authors: | Ferdowsi N; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Huq M; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Stevens W; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Hudson M; Medicine, University of McGill, Montreal, Quebec, Canada., Wang M; Lady Davis Institute for Medical Research, Montreal, Quebec, Canada., Tay T; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia.; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Burchell JL; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Mancuso S; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Rabusa C; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Sundararajan V; Public Health, LaTrobe University, Melbourne, Victoria, Australia., Prior D; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia., Proudman SM; Rheumatology, Royal Adelaide Hospital, Adelaide, Victoria, Australia., Baron M; Rheumatology, Jewish General Hospital, Montreal, Quebec, Canada., Nikpour M; Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia m.nikpour@unimelb.edu.au.; Rheumatology, St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia. |
| Corporate Authors: | Scleroderma Clinical Trials Consortium Damage Index Working Group, The Australian Scleroderma Interest Group, Canadian Scleroderma Research Group, Scleroderma Clinical Trials Consortium Damage Index Working Group, TheAustralian Scleroderma Interest Group, Canadian Scleroderma Research Group |
| Source: | Annals of the rheumatic diseases [Ann Rheum Dis] 2019 Jun; Vol. 78 (6), pp. 807-816. Date of Electronic Publication: 2019 Mar 30. |
| Publication Type: | Consensus Statement; Journal Article; Research Support, Non-U.S. Gov't; Validation Study |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
